Abstract
Background Exposure to per- and poly-fluoroalkyl substances (PFAS) remains an important public health issue due to their widespread detection and persistence in environmental media, slow metabolism in humans, and influences physiological processes such as neurological signaling. Maternal depression is highly prevalent during pregnancy and the postpartum period and is an important neurological outcome that is potentially sensitive to PFAS. The health risks associated with PFAS may be further amplified in historically marginalized communities, including immigrants.
Objective We evaluated the extent to which maternal concentrations of PFAS were associated with depression scores during pregnancy and whether effects differed between US born and immigrant women.
Methods Our analytical sample included 282 US born and 235 immigrant pregnant women enrolled in the Chemicals in Our Bodies prospective birth cohort based in San Francisco, CA. We measured 12 PFAS in serum samples collected in the second trimester and depressive symptom scores were assessed using the Center for Epidemiologic Studies Depression Scale in the same period. Associations were estimated using multiple linear regression, adjusting for maternal age, education, pre-pregnancy body mass index, and parity. Associations with a PFAS mixture were estimated using quantile g-computation.
Results In adjusted linear regression models, a natural log unit increase in two PFAS was associated with higher depression scores in the overall sample, and this association persisted only among immigrant women (β[95% confidence interval]: perfluorooctane sulfonic acid (1.3 [0.3-2.3]) and methyl-perfluorooctane sulfonamide acetic acid (1.5 [0.6-2.3]). Using quantile g-computation, we observed that simultaneously increasing all PFAS in the mixture by one quartile was associated with increased depressive symptoms among immigrant women (mean change per quartile increase= 1.12 [0.002, 2.3]), and associations were stronger compared to US born women (mean change per quartile increase= 0.09 [-1.0, 0.8]).
Conclusions Findings provide new evidence that PFAS are associated with higher depression symptoms among immigrant women during pregnancy. Results can inform efforts to address environmental factors that may affect depression among US immigrants.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by grants ES022848 and RD83543401 from the Children's Environmental Health and Disease Prevention Research Center, RD83543301 from the United States Environmental Protection Agency, P30 ES019776, P30 ES030284, P01ES022841 and R01ES02705 from the National Institute of Environmental Health Sciences, and UG3OD023272 and UH3OD023272 from the National Institutes of Health Environmental influences on Child Health Outcomes (ECHO) program. Dr. Aung's effort was partly funded by NIEHS core center grant P30ES007048.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All study participants provided written, informed consent prior to participation, and the Institutional Review Boards at the University of California San Francisco (13-12160) and the University of California, Berkeley (2010-05-04) approved the CIOB study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Per University of California, San Francisco Institutional Review Board approval, the data that support the findings of this study are restricted for transmission to those outside the primary investigative team. Data sharing with investigators outside the team requires IRB approval. Requests may be submitted to the Program on Reproductive Health and the Environment (PRHE)